Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Annals of intensive care

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M.
PMID: 27638133
Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15.

Neutropenia is defined by either an absolute or functional defect (acute myeloid leukemia or myelodysplastic syndrome) of polymorphonuclear neutrophils and is associated with high risk of specific complications that may require intensive care unit (ICU) admission. Specificities in the...

Cite
Schnell D, Azoulay E, Benoit D, et al. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care. 2016;6(1):90doi: 10.1186/s13613-016-0189-6.
Schnell, D., Azoulay, E., Benoit, D., Clouzeau, B., Demaret, P., Ducassou, S., Frange, P., Lafaurie, M., Legrand, M., Meert, A. P., Mokart, D., Naudin, J., Pene, F., Rabbat, A., Raffoux, E., Ribaud, P., Richard, J. C., Vincent, F., Zahar, J. R., & Darmon, M. (2016). Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Annals of intensive care, 6(1), 90. https://doi.org/10.1186/s13613-016-0189-6
Schnell, David, et al. "Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)." Annals of intensive care vol. 6,1 (2016): 90. doi: https://doi.org/10.1186/s13613-016-0189-6
Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M. Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF). Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15. PMID: 27638133; PMCID: PMC5025409.
Copy Download .nbib Format: NLM
Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma.

Frontiers in oncology

Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L, Muracciole X, Supiot S, Huchet A, Leseur J, Kerr C, Hangard G, Lisbona A, Goudjil F, Ferrand R, Laprie A.
PMID: 31293971
Front Oncol. 2019 Jun 21;9:531. doi: 10.3389/fonc.2019.00531. eCollection 2019.

No abstract available.

Cite
Tensaouti F, Ducassou A, Chaltiel L, et al. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Front Oncol. 2019;9:531doi: 10.3389/fonc.2019.00531.
Tensaouti, F., Ducassou, A., Chaltiel, L., Bolle, S., Habrand, J. L., Alapetite, C., Coche-Dequeant, B., Bernier, V., Claude, L., Carrie, C., Padovani, L., Muracciole, X., Supiot, S., Huchet, A., Leseur, J., Kerr, C., Hangard, G., Lisbona, A., Goudjil, F., Ferrand, R., & Laprie, A. (2019). Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Frontiers in oncology, 9531. https://doi.org/10.3389/fonc.2019.00531
Tensaouti, Fatima, et al. "Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma." Frontiers in oncology vol. 9 (2019): 531. doi: https://doi.org/10.3389/fonc.2019.00531
Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L, Muracciole X, Supiot S, Huchet A, Leseur J, Kerr C, Hangard G, Lisbona A, Goudjil F, Ferrand R, Laprie A. Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma. Front Oncol. 2019 Jun 21;9:531. doi: 10.3389/fonc.2019.00531. eCollection 2019. PMID: 31293971; PMCID: PMC6598548.
Copy Download .nbib Format: NLM
Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.

Blood

Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard JF, Lazaro E, Hermine O, Jouvray M, Machelard I, Lambilliotte A, Malphettes M, Moshous D, Neven B, Gauthier A, Garnier N, Leblanc T, Landman-Parker J, Leverger G, Aladjidi N.
PMID: 34714911
Blood. 2022 Jan 13;139(2):300-304. doi: 10.1182/blood.2021013496.

No abstract available.

Cite
Dhunputh C, Ducassou S, Fernandes H, et al. Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood. 2022;139(2):300-304doi: 10.1182/blood.2021013496.
Dhunputh, C., Ducassou, S., Fernandes, H., Picard, C., Rieux-Laucat, F., Viallard, J. F., Lazaro, E., Hermine, O., Jouvray, M., Machelard, I., Lambilliotte, A., Malphettes, M., Moshous, D., Neven, B., Gauthier, A., Garnier, N., Leblanc, T., Landman-Parker, J., Leverger, G., & Aladjidi, N. (2022). Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood, 139(2), 300-304. https://doi.org/10.1182/blood.2021013496
Dhunputh, C, et al. "Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects." Blood vol. 139,2 (2022): 300-304. doi: https://doi.org/10.1182/blood.2021013496
Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard JF, Lazaro E, Hermine O, Jouvray M, Machelard I, Lambilliotte A, Malphettes M, Moshous D, Neven B, Gauthier A, Garnier N, Leblanc T, Landman-Parker J, Leverger G, Aladjidi N. Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood. 2022 Jan 13;139(2):300-304. doi: 10.1182/blood.2021013496. PMID: 34714911.
Copy Download .nbib Format: NLM
Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study.

HemaSphere

Tabone MD, Kolta S, Auquier P, Vercasson C, Chastagner P, Kanold J, Rohrlich PS, Bertrand Y, Baruchel A, Plantaz D, Gandemer V, Ducassou S, Petit A, Paillard C, Leverger G, Dalle JH, Berbis J, Roux C, Michel G.
PMID: 33458594
Hemasphere. 2021 Jan 12;5(2):e518. doi: 10.1097/HS9.0000000000000518. eCollection 2021 Feb.

This prospective study aimed to analyze determinants that can influence bone mineral density evolution in childhood acute leukemia survivors. Patients included were selected from the long-term follow-up LEA cohort and had dual energy radiograph absorptiometry scan between 10 and...

Cite
Tabone MD, Kolta S, Auquier P, et al. Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study. Hemasphere. 2021;5(2):e518doi: 10.1097/HS9.0000000000000518.
Tabone, M. D., Kolta, S., Auquier, P., Vercasson, C., Chastagner, P., Kanold, J., Rohrlich, P. S., Bertrand, Y., Baruchel, A., Plantaz, D., Gandemer, V., Ducassou, S., Petit, A., Paillard, C., Leverger, G., Dalle, J. H., Berbis, J., Roux, C., & Michel, G. (2021). Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study. HemaSphere, 5(2), e518. https://doi.org/10.1097/HS9.0000000000000518
Tabone, Marie-Dominique, et al. "Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study." HemaSphere vol. 5,2 (2021): e518. doi: https://doi.org/10.1097/HS9.0000000000000518
Tabone MD, Kolta S, Auquier P, Vercasson C, Chastagner P, Kanold J, Rohrlich PS, Bertrand Y, Baruchel A, Plantaz D, Gandemer V, Ducassou S, Petit A, Paillard C, Leverger G, Dalle JH, Berbis J, Roux C, Michel G. Bone Mineral Density Evolution and Its Determinants in Long-term Survivors of Childhood Acute Leukemia: A Leucémies Enfants Adolescents Study. Hemasphere. 2021 Jan 12;5(2):e518. doi: 10.1097/HS9.0000000000000518. eCollection 2021 Feb. PMID: 33458594; PMCID: PMC7806242.
Copy Download .nbib Format: NLM
Abatacept is useful in auto-immune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.

Blood

Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard JF, Lazaro E, Olivier H, Jouvray M, Machelart I, Lambilliotte A, Malphettes M, Moshous D, Neven B, Gauthier A, Garnier N, Leblanc TM, Landman-Parker J, Leverger G, Aladjidi N.
PMID: 34714911
Blood. 2021 Oct 29; doi: 10.1182/blood.2021013496. Epub 2021 Oct 29.

No abstract available.

Cite
Dhunputh C, Ducassou S, Fernandes H, et al. Abatacept is useful in auto-immune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood. 2021;doi: 10.1182/blood.2021013496.
Dhunputh, C., Ducassou, S., Fernandes, H., Picard, C., Rieux-Laucat, F., Viallard, J. F., Lazaro, E., Olivier, H., Jouvray, M., Machelart, I., Lambilliotte, A., Malphettes, M., Moshous, D., Neven, B., Gauthier, A., Garnier, N., Leblanc, T. M., Landman-Parker, J., Leverger, G., & Aladjidi, N. (2021). Abatacept is useful in auto-immune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood, . https://doi.org/10.1182/blood.2021013496
Dhunputh, Chloé, et al. "Abatacept is useful in auto-immune cytopenia with immunopathologic manifestations caused by CTLA-4 defects." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2021013496
Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard JF, Lazaro E, Olivier H, Jouvray M, Machelart I, Lambilliotte A, Malphettes M, Moshous D, Neven B, Gauthier A, Garnier N, Leblanc TM, Landman-Parker J, Leverger G, Aladjidi N. Abatacept is useful in auto-immune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood. 2021 Oct 29; doi: 10.1182/blood.2021013496. Epub 2021 Oct 29. PMID: 34714911.
Copy Download .nbib Format: NLM
Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model.

Journal of contemporary brachytherapy

Brun T, Ferron G, Filleron T, Bonnet J, Martinez A, Ducassou A, Corbiere F, Delannes M.
PMID: 30479624
J Contemp Brachytherapy. 2018 Oct;10(5):463-469. doi: 10.5114/jcb.2018.79470. Epub 2018 Oct 31.

PURPOSE: The aim of this study is to investigate the feasibility of perioperative I-125 low-dose-rate brachytherapy mesh implantation in pelvic locations in an animal model, before applying it clinically.MATERIAL AND METHODS: The animal model was the Romanov adult ewe....

Cite
Brun T, Ferron G, Filleron T, et al. Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model. J Contemp Brachytherapy. 2018;10(5):463-469doi: 10.5114/jcb.2018.79470.
Brun, T., Ferron, G., Filleron, T., Bonnet, J., Martinez, A., Ducassou, A., Corbiere, F., & Delannes, M. (2018). Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model. Journal of contemporary brachytherapy, 10(5), 463-469. https://doi.org/10.5114/jcb.2018.79470
Brun, Thomas, et al. "Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model." Journal of contemporary brachytherapy vol. 10,5 (2018): 463-469. doi: https://doi.org/10.5114/jcb.2018.79470
Brun T, Ferron G, Filleron T, Bonnet J, Martinez A, Ducassou A, Corbiere F, Delannes M. Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model. J Contemp Brachytherapy. 2018 Oct;10(5):463-469. doi: 10.5114/jcb.2018.79470. Epub 2018 Oct 31. PMID: 30479624; PMCID: PMC6251451.
Copy Download .nbib Format: NLM
Clear cell adenocarcinoma arising from the abdominal wall after cesarean section in a patient with uterine adenomyosis.

Journal of surgical case reports

Provendier A, Angeles MA, Meyrignac O, Illac C, Ducassou A, Martínez-Gómez C, Gladieff L, Martinez A, Ferron G.
PMID: 32280445
J Surg Case Rep. 2020 Apr 07;2020(4):rjaa070. doi: 10.1093/jscr/rjaa070. eCollection 2020 Apr.

Malignant transformation of abdominal wall endometriosis lesions developed in a cesarean section scar is a rare event. Patients with uterine adenomyosis but without endometriosis can also develop abdominal wall malignant carcinoma after a gynecologic surgery. The treatment of abdominal...

Cite
Provendier A, Angeles MA, Meyrignac O, et al. Clear cell adenocarcinoma arising from the abdominal wall after cesarean section in a patient with uterine adenomyosis. J Surg Case Rep. 2020;2020(4):rjaa070doi: 10.1093/jscr/rjaa070.
Provendier, A., Angeles, M. A., Meyrignac, O., Illac, C., Ducassou, A., Martínez-Gómez, C., Gladieff, L., Martinez, A., & Ferron, G. (2020). Clear cell adenocarcinoma arising from the abdominal wall after cesarean section in a patient with uterine adenomyosis. Journal of surgical case reports, 2020(4), rjaa070. https://doi.org/10.1093/jscr/rjaa070
Provendier, Anaïs, et al. "Clear cell adenocarcinoma arising from the abdominal wall after cesarean section in a patient with uterine adenomyosis." Journal of surgical case reports vol. 2020,4 (2020): rjaa070. doi: https://doi.org/10.1093/jscr/rjaa070
Provendier A, Angeles MA, Meyrignac O, Illac C, Ducassou A, Martínez-Gómez C, Gladieff L, Martinez A, Ferron G. Clear cell adenocarcinoma arising from the abdominal wall after cesarean section in a patient with uterine adenomyosis. J Surg Case Rep. 2020 Apr 07;2020(4):rjaa070. doi: 10.1093/jscr/rjaa070. eCollection 2020 Apr. PMID: 32280445; PMCID: PMC7136835.
Copy Download .nbib Format: NLM
Extracellular riboflavin induces anaerobic biofilm formation in Shewanella oneidensis.

Biotechnology for biofuels

Edel M, Sturm G, Sturm-Richter K, Wagner M, Ducassou JN, Couté Y, Horn H, Gescher J.
PMID: 34082787
Biotechnol Biofuels. 2021 Jun 03;14(1):130. doi: 10.1186/s13068-021-01981-3.

BACKGROUND: Some microorganisms can respire with extracellular electron acceptors using an extended electron transport chain to the cell surface. This process can be applied in bioelectrochemical systems in which the organisms produce an electrical current by respiring with an...

Cite
Edel M, Sturm G, Sturm-Richter K, et al. Extracellular riboflavin induces anaerobic biofilm formation in Shewanella oneidensis. Biotechnol Biofuels. 2021;14(1):130doi: 10.1186/s13068-021-01981-3.
Edel, M., Sturm, G., Sturm-Richter, K., Wagner, M., Ducassou, J. N., Couté, Y., Horn, H., & Gescher, J. (2021). Extracellular riboflavin induces anaerobic biofilm formation in Shewanella oneidensis. Biotechnology for biofuels, 14(1), 130. https://doi.org/10.1186/s13068-021-01981-3
Edel, Miriam, et al. "Extracellular riboflavin induces anaerobic biofilm formation in Shewanella oneidensis." Biotechnology for biofuels vol. 14,1 (2021): 130. doi: https://doi.org/10.1186/s13068-021-01981-3
Edel M, Sturm G, Sturm-Richter K, Wagner M, Ducassou JN, Couté Y, Horn H, Gescher J. Extracellular riboflavin induces anaerobic biofilm formation in Shewanella oneidensis. Biotechnol Biofuels. 2021 Jun 03;14(1):130. doi: 10.1186/s13068-021-01981-3. PMID: 34082787; PMCID: PMC8176591.
Copy Download .nbib Format: NLM
If «Me» is not as it seems, what about diagnosing and treating mental illness?.

Explore (New York, N.Y.)

Ducasse D, Van Gordon W, Courtet P.
PMID: 32387129
Explore (NY). 2020 Jul - Aug;16(4):206-207. doi: 10.1016/j.explore.2020.02.010. Epub 2020 Feb 27.

No abstract available.

Cite
Ducasse D, Van Gordon W, Courtet P. If «Me» is not as it seems, what about diagnosing and treating mental illness?. Explore (NY). 2020;16(4):206-207doi: 10.1016/j.explore.2020.02.010.
Ducasse, D., Van Gordon, W., & Courtet, P. (2020). If «Me» is not as it seems, what about diagnosing and treating mental illness?. Explore (New York, N.Y.), 16(4), 206-207. https://doi.org/10.1016/j.explore.2020.02.010
Ducasse, Déborah, et al. "If «Me» is not as it seems, what about diagnosing and treating mental illness?." Explore (New York, N.Y.) vol. 16,4 (2020): 206-207. doi: https://doi.org/10.1016/j.explore.2020.02.010
Ducasse D, Van Gordon W, Courtet P. If «Me» is not as it seems, what about diagnosing and treating mental illness?. Explore (NY). 2020 Jul - Aug;16(4):206-207. doi: 10.1016/j.explore.2020.02.010. Epub 2020 Feb 27. PMID: 32387129.
Copy Download .nbib Format: NLM
Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Attal J, Cabarrou B, Valentin T, Nesseler JP, Stoeckle E, Ducassou A, Filleron T, Le Guellec S, Boulet B, Vogin G, Ferron G, Moyal EC, Delannes M, Chevreau C.
PMID: 34673991
Strahlenther Onkol. 2021 Dec;197(12):1051-1062. doi: 10.1007/s00066-021-01847-5. Epub 2021 Oct 21.

PURPOSE: Patients with locally advanced grade 2-3 extremity/truncal soft tissue sarcomas (STS) are at high risk of recurrence. The objective of this study was to assess the efficacy and feasibility of neoadjuvant concurrent chemoradiotherapy (cCRT) in selected grade 2-3...

Cite
Attal J, Cabarrou B, Valentin T, et al. Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment. Strahlenther Onkol. 2021;197(12):1051-1062doi: 10.1007/s00066-021-01847-5.
Attal, J., Cabarrou, B., Valentin, T., Nesseler, J. P., Stoeckle, E., Ducassou, A., Filleron, T., Le Guellec, S., Boulet, B., Vogin, G., Ferron, G., Moyal, E. C., Delannes, M., & Chevreau, C. (2021). Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 197(12), 1051-1062. https://doi.org/10.1007/s00066-021-01847-5
Attal, J, et al. "Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 197,12 (2021): 1051-1062. doi: https://doi.org/10.1007/s00066-021-01847-5
Attal J, Cabarrou B, Valentin T, Nesseler JP, Stoeckle E, Ducassou A, Filleron T, Le Guellec S, Boulet B, Vogin G, Ferron G, Moyal EC, Delannes M, Chevreau C. Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment. Strahlenther Onkol. 2021 Dec;197(12):1051-1062. doi: 10.1007/s00066-021-01847-5. Epub 2021 Oct 21. PMID: 34673991.
Copy Download .nbib Format: NLM
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence.

Clinical and translational radiation oncology

Baudou E, Pariente J, Péran P, Tensaouti F, Pollidoro L, Meligne D, Ducassou A, Gros-Dagnac H, Arribarat G, Desirat JP, Bertozzi AI, Gambart M, Larrieu-Ciron D, Barbolosi D, Muracciole X, Lemesle B, Sevely A, Roques M, Cazaux M, Tallet J, Danna J, Chaix Y, Laprie A.
PMID: 34988299
Clin Transl Radiat Oncol. 2021 Nov 07;33:7-14. doi: 10.1016/j.ctro.2021.10.006. eCollection 2022 Mar.

BACKGROUND: Posterior fossa tumors represent two thirds of brain tumors in children. Although progress in treatment has improved survival rates over the past few years, long-term memory impairments in survivors are frequent and have an impact on academic achievement....

Cite
Baudou E, Pariente J, Péran P, et al. A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clin Transl Radiat Oncol. 2021;33:7-14doi: 10.1016/j.ctro.2021.10.006.
Baudou, E., Pariente, J., Péran, P., Tensaouti, F., Pollidoro, L., Meligne, D., Ducassou, A., Gros-Dagnac, H., Arribarat, G., Desirat, J. P., Bertozzi, A. I., Gambart, M., Larrieu-Ciron, D., Barbolosi, D., Muracciole, X., Lemesle, B., Sevely, A., Roques, M., Cazaux, M., Tallet, J., Danna, J., Chaix, Y., & Laprie, A. (2022). A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clinical and translational radiation oncology, 337-14. https://doi.org/10.1016/j.ctro.2021.10.006
Baudou, Eloïse, et al. "A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence." Clinical and translational radiation oncology vol. 33 (2022): 7-14. doi: https://doi.org/10.1016/j.ctro.2021.10.006
Baudou E, Pariente J, Péran P, Tensaouti F, Pollidoro L, Meligne D, Ducassou A, Gros-Dagnac H, Arribarat G, Desirat JP, Bertozzi AI, Gambart M, Larrieu-Ciron D, Barbolosi D, Muracciole X, Lemesle B, Sevely A, Roques M, Cazaux M, Tallet J, Danna J, Chaix Y, Laprie A. A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clin Transl Radiat Oncol. 2021 Nov 07;33:7-14. doi: 10.1016/j.ctro.2021.10.006. eCollection 2022 Mar. PMID: 34988299; PMCID: PMC8703178.
Copy Download .nbib Format: NLM
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence.

Clinical and translational radiation oncology

Baudou E, Pariente J, Péran P, Tensaouti F, Pollidoro L, Meligne D, Ducassou A, Gros-Dagnac H, Arribarat G, Desirat JP, Bertozzi AI, Gambart M, Larrieu-Ciron D, Barbolosi D, Muracciole X, Lemesle B, Sevely A, Roques M, Cazaux M, Tallet J, Danna J, Chaix Y, Laprie A.
PMID: 34988299
Clin Transl Radiat Oncol. 2021 Nov 07;33:7-14. doi: 10.1016/j.ctro.2021.10.006. eCollection 2022 Mar.

BACKGROUND: Posterior fossa tumors represent two thirds of brain tumors in children. Although progress in treatment has improved survival rates over the past few years, long-term memory impairments in survivors are frequent and have an impact on academic achievement....

Cite
Baudou E, Pariente J, Péran P, et al. A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clin Transl Radiat Oncol. 2021;33:7-14doi: 10.1016/j.ctro.2021.10.006.
Baudou, E., Pariente, J., Péran, P., Tensaouti, F., Pollidoro, L., Meligne, D., Ducassou, A., Gros-Dagnac, H., Arribarat, G., Desirat, J. P., Bertozzi, A. I., Gambart, M., Larrieu-Ciron, D., Barbolosi, D., Muracciole, X., Lemesle, B., Sevely, A., Roques, M., Cazaux, M., Tallet, J., Danna, J., Chaix, Y., & Laprie, A. (2022). A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clinical and translational radiation oncology, 337-14. https://doi.org/10.1016/j.ctro.2021.10.006
Baudou, Eloïse, et al. "A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence." Clinical and translational radiation oncology vol. 33 (2022): 7-14. doi: https://doi.org/10.1016/j.ctro.2021.10.006
Baudou E, Pariente J, Péran P, Tensaouti F, Pollidoro L, Meligne D, Ducassou A, Gros-Dagnac H, Arribarat G, Desirat JP, Bertozzi AI, Gambart M, Larrieu-Ciron D, Barbolosi D, Muracciole X, Lemesle B, Sevely A, Roques M, Cazaux M, Tallet J, Danna J, Chaix Y, Laprie A. A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clin Transl Radiat Oncol. 2021 Nov 07;33:7-14. doi: 10.1016/j.ctro.2021.10.006. eCollection 2022 Mar. PMID: 34988299; PMCID: PMC8703178.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries